AssetMark Inc
IONS icon

AssetMark Inc’s Ionis Pharmaceuticals IONS Stock Holding History

AssetMark Inc’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$5.58K Sell
125
-9,814
-99% -$558K ﹤0.01% 2734
2026
Q2 		$788K Buy
9,939
+365
+4% +$27.5K ﹤0.01% 1133
2026
Q1 		$719K Buy
9,574
+924
+11% +$72.9K ﹤0.01% 1096
2025
Q4 		$684K Buy
8,650
+8,575
+11,433% +$646K ﹤0.01% 1089
2025
Q3 		$4.91K Hold
75
– – ﹤0.01% 2348
2025
Q2 		$2.96K Buy
75
+60
+400% +$1.96K ﹤0.01% 2306
2025
Q1 		$453 Sell
15
-17
-53% -$557 ﹤0.01% 2435
2024
Q4 		$1.12K Buy
+32
New +$1.2K ﹤0.01% 2222
2024
Q2 		– Sell
-1
Closed -$43 – 2175
2024
Q1 		$43 Sell
1
-6
-86% -$286 ﹤0.01% 1848
2023
Q4 		$354 Buy
+7
New +$335 ﹤0.01% 1705
2022
Q4 		– Sell
-250
Closed -$11K – 1621
2022
Q3 		$11K Buy
+250
New +$10.5K ﹤0.01% 1213
2019
Q4 		– Sell
-25
Closed -$2K – 1428
2019
Q3 		$2K Hold
25
– – ﹤0.01% 1169
2019
Q2 		$2K Hold
25
– – ﹤0.01% 1166
2019
Q1 		$2K Hold
25
– – ﹤0.01% 1171
2018
Q4 		$1K Hold
25
– – ﹤0.01% 1319
2018
Q3 		$1K Hold
25
– – ﹤0.01% 1344
2018
Q2 		$1K Hold
25
– – ﹤0.01% 1343
2018
Q1 		$1K Sell
25
-46
-65% -$2.34K ﹤0.01% 1338
2017
Q4 		$4K Buy
71
+66
+1,320% +$3.62K ﹤0.01% 1292
2017
Q3 		$0 Buy
+5
New +$262 ﹤0.01% 1538

Other funds holding IONS

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Tweedy, Browne Co
Tweedy, Browne Co Stamford, Connecticut $1.23B AUM 16.54% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
C WorldWide Group
C WorldWide Group Copenhagen, Denmark $3.96B AUM 10.41% 1-Year Est. Return
Privium Fund Management
Privium Fund Management Amsterdam, Netherlands $516M AUM 18.66% 1-Year Est. Return

AssetMark Inc's IONS Position: Q3 2026 in Review

AssetMark Inc reduced its Ionis Pharmaceuticals (IONS) stake by 99% in Q3 2026, selling an estimated $558K and leaving 125 shares worth $5.58K. The position accounts for ﹤0.01% of the portfolio, ranked #2734.

AssetMark Inc first reported a position in IONS in Q3 2017 and has held it in 20 quarters since. The position peaked at $788K in Q2 2026. 175 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • AssetMark Inc held 125 shares of Ionis Pharmaceuticals worth $5.58K as of Q3 2026.
  • AssetMark Inc sold 9,814 Ionis Pharmaceuticals shares in Q3 2026, an estimated $558K.
  • Ionis Pharmaceuticals made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #2734 holding.
  • AssetMark Inc first reported a position in Ionis Pharmaceuticals in Q3 2017 and has held it in 20 quarters since.
  • AssetMark Inc's Ionis Pharmaceuticals position peaked at $788K in Q2 2026.
  • 175 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.